Ventricular flutter
Methodology & AI Transparency ⓘ
Ventricular flutter Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Heart & Cardiovascular Disease practice, Ventricular flutter (ICD-10 I49.02) is stratified through cardiopulmonary biomarker stratification [Ventricular flutter I49.02], pairing targeted symptom control with longitudinal Left Ventricular Ejection in Ventricular flutter (I49.02: Fraction (LVEF)) surveillance.
- 2 Real-world patient consensus: Mapped to Heart & Cardiovascular Disease under ICD-10-CM I49.02 for Ventricular flutter clinical workups.
- 3 Typical cash cost range: Clinicians assessing Ventricular flutter focus on electrical conduction pathway in Ventricular flutter (I49.02: remodeling) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Ventricular flutter: Apolipoprotein B (ApoB) [Ventricular flutter I49.02] (< 70 mg/dL (I49.02)) and Left Ventricular Ejection in Ventricular flutter (I49.02: Fraction (LVEF)).
Ask our AI Specialists anything about Ventricular flutter
What Is Ventricular flutter?
Within Heart & Cardiovascular Disease practice, Ventricular flutter (ICD-10 I49.02) is stratified through cardiopulmonary biomarker stratification [Ventricular flutter I49.02], pairing targeted symptom control with longitudinal Left Ventricular Ejection in Ventricular flutter (I49.02: Fraction (LVEF)) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Ventricular flutter (ICD-10 I49.02) is driven by electrical conduction pathway in Ventricular flutter (I49.02: remodeling); specialists in Heart & Cardiovascular Disease monitor Left Ventricular Ejection in Ventricular flutter (I49.02: Fraction (LVEF)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Ventricular flutter (I49.02): palpitations, skipped beats, in Ventricular flutter (I49.02: or irregular resting)
- • Secondary Ventricular flutter clinical sign: unexplained lower-extremity ankle in Ventricular flutter (I49.02: edema or rapid)
- • Symptom flares in Ventricular flutter correlating with Apolipoprotein B (ApoB) [Ventricular flutter I49.02] deviation outside < 70 mg/dL (I49.02)
- • Functional heart & vascular impact requiring cardiopulmonary biomarker stratification [Ventricular flutter I49.02] evaluation (I49.02)
Ventricular flutter Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I49.02 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Apolipoprotein B (ApoB) [Ventricular flutter I49.02] | < 70 mg/dL (I49.02) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Left Ventricular Ejection in Ventricular flutter (I49.02: Fraction (LVEF)) | 55% – 70% (I49.02) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [Ventricular flutter I49.02] | < 100 pg/mL (I49.02) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Ventricular flutter
Treatment selection for Ventricular flutter depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Ventricular flutter)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Obstructive sleep apnoea syndrome and left ventricular: What a 5,550-Participant Study Found The present meta-analysis expands previous information on the relationship between OSA and echocardiographic LVH, so far based on individual studies. Journal of hypertension • 2020-09-15 • Meta-Analysis | N = 5,550 | 94/100 | PMID 32371766 ↗ |
| New Insights on Diuretic resistance predicts mortality in patients with advanced heart: What a 1,153-Participant Study Found The independent association of high diuretic doses with mortality suggests that diuretic resistance should be considered an indicator of prognosis in patients with chronic CHF. American heart journal • 2002-07-15 • Randomized Controlled Trial | N = 1,153 | 90/100 | PMID 12094185 ↗ |
| New Insights on Electrocardiographic Left Ventricular Hypertrophy Predicts heart and blood vessel: What a 33,357-Participant Study Found Baseline Cornell voltage LVH is associated with increased CV morbidity and all-cause mortality in treated hypertensive patients independent of treatment modality and other CV risk factors. American journal of hypertension • 2017-09-01 • Randomized Controlled Trial | N = 33,357 | 90/100 | PMID 28430947 ↗ |
| Can This Approach Help? Inside the Latest Research on Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Treatment of patients with stage I high blood pressure for 18 months promotes favorable effects in the LA and LV remodeling. American journal of hypertension • 2018-02-09 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 29036504 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Cardioprotection on the Right Ventricular Function in Breast Cancer Short-term neurohormonal cardioprotection was effective in reducing RV CTRCD. Echocardiography (Mount Kisco, N.Y.) • 2025-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40965835 ↗ |
Ventricular flutter Patient Community & “People Like Me” Threads
Filter Ventricular flutter community threads and patient logs by age, biological sex, dosage, and treatment duration.